
Kisspeptin
Kisspeptin reliably raises LH, FSH and testosterone for hours in research studies, and single doses of kisspeptin-54 have triggered egg maturation in small IVF studies at one London clinic. Short studies also found changes in brain responses to sexual cues in people with low sexual desire. All of this comes from small, supervised studies, mostly with infusions into a vein; there are no trials of the injections sold online, no long-term safety data, and no approved product.
Research compound: not an approved drug or dietary supplement
This compound is sold for research and is not FDA-approved for human use or as a dietary supplement. Human evidence is limited; purity and dosing of consumer products are unverified. The data below is an evidence review for education only. Talk to a clinician before considering it.
Quick decision guide
May help most
Research participants in registered clinical trials; there is no approved use
Common dosing range
No approved or established dose. Studies used weight-based infusions or single injections under supervision
When to expect effects
LH rises within 30 minutes of an intravenous dose; repeated dosing can blunt the response
Watch out for
Not FDA-approved for any use; FDA lists kisspeptin-10 as a compounding substance that may present significant safety risks; repeated or continuous dosing can desensitize or even suppress the hormone system; "research" products are unverified
What is it
Kisspeptin is a natural hormone that switches on the body's reproductive hormone system by triggering the release of GnRH from the brain, which in turn raises LH, FSH and, in men, testosterone. Lab-made versions, mainly kisspeptin-54 and the short form kisspeptin-10, have been given to volunteers and patients in university research studies, usually as an infusion into a vein or as a single injection under close supervision. No kisspeptin product is approved by FDA for any use, and no approved product exists in the US to compare against. FDA has listed kisspeptin-10 in category 2 for pharmacy compounding (bulk substances that may present significant safety risks) since September 29, 2023, and it was still there in FDA's list updated May 14, 2026. Products sold online as kisspeptin-10 for "research" are unapproved, and their purity and dose are unverified.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
LH and testosterone levels in healthy men Limited Evidence | LH about 3-fold higher within 30 minutes of one intravenous dose; smaller sustained rises with daily 8-hour infusions | Healthy men in research studies | Within 30 minutes; the effect fades with continuous exposure |
triggering egg maturation during IVF Limited Evidence | Egg maturation in 95% of high-risk women; live birth 45% per transfer (no standard-trigger comparison group) | Women undergoing IVF at high risk of OHSS, within a research program | Eggs collected 36 hours after the injection |
brain responses to sexual cues in low sexual desire (HSDD) Limited Evidence | Changes in brain activity on MRI; penile tumescence up to 56% more than placebo during one infusion (men) | Research participants with HSDD | During a single infusion |
LH and testosterone levels in healthy men
- Effect
- LH about 3-fold higher within 30 minutes of one intravenous dose; smaller sustained rises with daily 8-hour infusions
- Best fit
- Healthy men in research studies
- Time
- Within 30 minutes; the effect fades with continuous exposure
triggering egg maturation during IVF
- Effect
- Egg maturation in 95% of high-risk women; live birth 45% per transfer (no standard-trigger comparison group)
- Best fit
- Women undergoing IVF at high risk of OHSS, within a research program
- Time
- Eggs collected 36 hours after the injection
brain responses to sexual cues in low sexual desire (HSDD)
- Effect
- Changes in brain activity on MRI; penile tumescence up to 56% more than placebo during one infusion (men)
- Best fit
- Research participants with HSDD
- Time
- During a single infusion
Evidence for 3 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
LH and testosterone levels in healthy men
Biomarker supportIn healthy men, a single intravenous dose of kisspeptin-10 raised LH from 4.1 to 12.4 IU/L within 30 minutes (at 1 microgram per kg, 6 men), and a 22.5-hour infusion raised testosterone from 16.6 to 24.0 nmol/L (4 men). In a 2026 randomized, single-blind, placebo-controlled study in 15 healthy men, infusions under the skin raised LH, FSH and testosterone; with a continuous 5-day infusion, testosterone stayed higher but LH and FSH fell back to placebo levels, while daily 8-hour infusions kept LH higher for 12 days (mean LH rise +1.68 on day 1 and +1.14 on day 12, versus -0.16 on vehicle; 12 men served as controls). These are hormone levels in healthy volunteers using pumps in research units. Men with low testosterone, symptoms, and the injections sold online were not studied in these trials.
Bottom line: It raises reproductive hormones for hours in healthy men, but only with careful timing, and no symptom benefit has been tested.
triggering egg maturation during IVF
Disease adjunctAt one London IVF clinic, a single injection of kisspeptin-54 under the skin was used instead of the usual trigger shot. In 53 women with subfertility, eggs matured at every dose tested, embryos were transferred in 92%, and the clinical pregnancy rate was 23% (12 of 53). In a phase 2 randomized dose-finding trial of 60 women at high risk of ovarian hyperstimulation syndrome (OHSS), eggs matured in 95%; per embryo transfer, clinical pregnancy was 53% and live birth 45%, and no woman developed moderate, severe or critical OHSS. Neither study compared kisspeptin with a standard trigger, both were run by the same research group, and these were specialist-controlled single doses during IVF, not use at home.
Bottom line: A promising research approach for one step of IVF, not a fertility product for home use.
brain responses to sexual cues in low sexual desire (HSDD)
Biomarker supportTwo randomized, double-blind, placebo-controlled crossover trials gave a single 75-minute intravenous infusion of kisspeptin-54. In 32 premenopausal women with hypoactive sexual desire disorder (mean age 29), it changed activity in brain areas involved in sexual and attraction processing on MRI and was well tolerated, with no reported side effects. In 32 men with HSDD (mean age 38), it changed brain activity in the sexual-processing network compared with placebo, increased penile tumescence (swelling) in response to sexual videos by up to 56% more than placebo, and raised a score for happiness about sex (mean difference 0.63 points); these were secondary results. These were single infusions in a scanner, measuring brain signals and lab responses; whether repeated doses improve desire or sexual satisfaction in daily life has not been tested.
Bottom line: One infusion changed brain and arousal measures in a lab; it is not a proven libido treatment.
How it works
How to take it
What to track
Bottom line: No approved dose exists; outside a trial there is no safe, verified way to use it.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
FDA safety concerns for compounding. FDA placed kisspeptin-10 in category 2 for pharmacy compounding on September 29, 2023, saying compounded kisspeptin-10 may pose a risk of immune reactions for certain routes, may have problems with peptide-related impurities and characterization, and that FDA has no or only limited safety information, so it cannot know whether it would cause harm in people.
Desensitization of the hormone system. In women with hypothalamic amenorrhea, twice-daily kisspeptin-54 injections for 2 weeks (5 women per group) shrank the peak LH rise after an injection from 24.0 IU/L on day 1 to 2.5 IU/L on day 14, so the response largely faded.
Suppression of testosterone with continuous exposure. A long-acting kisspeptin-type drug (TAK-448) given as a 14-day infusion at doses above 0.1 mg a day lowered testosterone below baseline by 60 hours and to castration levels by day 8 in healthy men aged 50 or older. This is the opposite of the boost sellers promise.
Unknown long-term safety and unverified products. Published studies were short: the longest found gave twice-weekly injections for 8 weeks to women with hypothalamic amenorrhea, and others lasted from one dose to 2 weeks. Compounded drugs are not FDA-approved, so FDA does not check their safety, effectiveness or quality, and "research" vials are not made for people.
Who should avoid it
- Anyone outside a supervised clinical trial, since FDA lists kisspeptin-10 as a compounding substance that may present significant safety risks and no product is approved
- Men on testosterone therapy or with hormone-related conditions, unless a specialist is involved: continuous kisspeptin-type drugs suppressed testosterone
- People trying to conceive without a fertility specialist: in IVF studies it was used only as a single, timed dose with hormone and ultrasound monitoring
Pregnancy & breastfeeding
Kisspeptin has not been studied as a medicine during pregnancy or breastfeeding. In IVF research it was given once, before egg collection, under specialist care, not during pregnancy. Because it acts directly on reproductive hormones, ask your doctor before any use if you are pregnant, breastfeeding or trying to conceive.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Is kisspeptin FDA-approved?⌄
No. No kisspeptin product is approved by FDA for any use. It is a research compound studied in universities, mostly as infusions into a vein given under supervision.
Can a pharmacy compound kisspeptin-10 for me?⌄
FDA has listed kisspeptin-10 in category 2 under its interim policy for pharmacy compounding since September 29, 2023, which is its group of bulk substances that may present significant safety risks. FDA says it has no or only limited safety information on the proposed routes and is concerned about immune reactions and impurities. It remained in that category on FDA's list updated May 14, 2026.
Will kisspeptin raise my testosterone?⌄
For a few hours, in research studies, yes: LH and testosterone rose after doses into a vein or under the skin. But repeated twice-daily injections made the response fade, and a continuous kisspeptin-type drug pushed testosterone down to castration levels. No study has shown symptom benefits in men with low testosterone. Talk with your doctor about approved options.
Does kisspeptin help with fertility or IVF?⌄
In small studies at one London IVF clinic, a single injection of kisspeptin-54 matured eggs, and some women went on to have babies, including women at high risk of ovarian hyperstimulation. These studies did not compare it with the standard trigger shot, and it is not available as an approved product.
Does it work for low sexual desire?⌄
One infusion changed brain responses to sexual images in women and men with hypoactive sexual desire disorder, and increased penile tumescence in men during the test. Whether it improves desire in daily life is unknown. An approved medicine for this condition in premenopausal women, bremelanotide (Vyleesi), works in a different way; ask your doctor about it.
Can I take kisspeptin with my supplements?⌄
No interaction studies with supplements or other medicines exist, so nothing is known about combining it with them. A doctor or pharmacist should check your full list.
References by claim
LH and testosterone levels in healthy men
triggering egg maturation during IVF
brain responses to sexual cues in low sexual desire (HSDD)
Safety
FDA: Certain bulk drug substances for use in compounding that may present significant safety risks · FDA link
FDA: Bulk drug substances nominated for use in compounding under section 503A (updated May 14, 2026) · FDA link
Jayasena et al., 2009 · PubMed (2009) link
MacLean et al., 2014 · PubMed (2014) link
Jayasena et al., 2010 · PubMed (2010) link
FDA: Compounding and the FDA, questions and answers · FDA link
Track Kisspeptin with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This compound is not approved by the FDA for human use and is not a dietary supplement. This page is an educational review of available research (much of it preclinical or early-stage), not a recommendation to use it. Consumer product quality is unregulated. Consult a qualified clinician.
